关注
Oliver Pötz
Oliver Pötz
Ceo, SIGNATOPE GmbH, Germany
在 signatope.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Protein microarrays: promising tools for proteomic research
MF Templin, D Stoll, JM Schwenk, O Pötz, S Kramer, TO Joos
Proteomics 3 (11), 2155-2166, 2003
3262003
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors
M Bauer, A Chicca, M Tamborrini, D Eisen, R Lerner, B Lutz, O Poetz, ...
Journal of biological chemistry 287 (44), 36944-36967, 2012
1862012
Protein microarrays: catching the proteome
O Poetz, JM Schwenk, S Kramer, D Stoll, MF Templin, TO Joos
Mechanisms of ageing and development 126 (1), 161-170, 2005
1462005
Peptides in headlock–a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
MB Braun, B Traenkle, PA Koch, F Emele, F Weiss, O Poetz, T Stehle, ...
Scientific reports 6 (1), 19211, 2016
1372016
Protein microarrays for antibody profiling: specificity and affinity determination on a chip
O Poetz, R Ostendorp, B Brocks, JM Schwenk, D Stoll, TO Joos, ...
Proteomics 5 (9), 2402-2411, 2005
1322005
Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells
H Kempf, R Olmer, A Haase, A Franke, E Bolesani, K Schwanke, ...
Nature communications 7 (1), 13602, 2016
1222016
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition
F Beck, J Geiger, S Gambaryan, FA Solari, M Dell’Aica, S Loroch, ...
Blood, The Journal of the American Society of Hematology 129 (2), e1-e12, 2017
1152017
Variability in mass spectrometry-based quantification of clinically relevant drug transporters and drug metabolizing enzymes
C Wegler, FZ Gaugaz, TB Andersson, JR Wiśniewski, D Busch, C Gröer, ...
Molecular pharmaceutics 14 (9), 3142-3151, 2017
1112017
A bead-based western for high-throughput cellular signal transduction analyses
F Treindl, B Ruprecht, Y Beiter, S Schultz, A Döttinger, A Staebler, ...
Nature communications 7 (1), 12852, 2016
1072016
Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells*[S]
B Traenkle, F Emele, R Anton, O Poetz, RS Haeussler, J Maier, PD Kaiser, ...
Molecular & Cellular Proteomics 14 (3), 707-723, 2015
872015
Conditional disruption of Axin1 leads to development of liver tumors in mice
GJ Feng, W Cotta, XQ Wei, O Poetz, R Evans, T Jardé, K Reed, V Meniel, ...
Gastroenterology 143 (6), 1650-1659, 2012
672012
Proteome wide screening using peptide affinity capture
O Poetz, S Hoeppe, MF Templin, D Stoll, TO Joos
Proteomics 9 (6), 1518-1523, 2009
662009
Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification
S Hoeppe, TD Schreiber, H Planatscher, A Zell, MF Templin, D Stoll, ...
Molecular & Cellular Proteomics 10 (2), S1-S11, 2011
642011
Cross-species analysis of hepatic cytochrome P450 and transport protein expression
H Hammer, F Schmidt, P Marx-Stoelting, O Pötz, A Braeuning
Archives of toxicology 95 (1), 117-133, 2021
622021
Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome
B Bigalke, K Stellos, D Stakos, T Joos, O Pötz, T Geisler, C Bischofs, ...
Thrombosis and haemostasis 101 (05), 911-915, 2009
582009
Concurrent epigenetic silencing of Wnt/beta-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
EA Moskalev, K Luckert, IA Vorobjev, SE Mastitsky, AA Gladkikh, ...
BMC cancer 12 (1), 213, 2012
552012
A nexus consisting of beta-catenin and Stat3 attenuates BRAF inhibitor efficacy and mediates acquired resistance to vemurafenib
T Sinnberg, E Makino, MA Krueger, A Velic, B Macek, U Rothbauer, ...
EBioMedicine 8, 132-149, 2016
542016
Catch and measure–mass spectrometry‐based immunoassays in biomarker research
F Weiß, BHJ van den Berg, H Planatscher, CJ Pynn, TO Joos, O Poetz
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844 (5), 927-932, 2014
492014
Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)
B Bigalke, K Stellos, HJ Weig, T Geisler, P Seizer, E Kremmer, O Pötz, ...
Basic research in cardiology 104, 352-357, 2009
492009
New approach methodologies in human regulatory toxicology–Not if, but how and when!
S Schmeisser, A Miccoli, M von Bergen, E Berggren, A Braeuning, ...
Environment international, 108082, 2023
472023
系统目前无法执行此操作,请稍后再试。
文章 1–20